We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
AUM
$324M
AUM Growth
-$19.1M
Cap. Flow
-$15M
Cap. Flow %
-4.62%
Top 10 Hldgs %
68.58%
Holding
184
New
7
Increased
19
Reduced
72
Closed
30

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.04M
2
MRK icon
Merck
MRK
+$1.34M
3
UNP icon
Union Pacific
UNP
+$1.08M
4
IWN icon
iShares Russell 2000 Value ETF
IWN
+$911K
5
PLD icon
Prologis
PLD
+$903K

Sector Composition

Rank Sector Weight
1 Technology 9.39%
2 Financials 6.68%
3 Healthcare 4.39%
4 Industrials 3.89%
5 Consumer Discretionary 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
51
Novartis
NVS
$295B
$734K 0.23%
7,542
-66
-0.9% -$7.04K
ISRG icon
52
Intuitive Surgical
ISRG
$121B
$729K 0.22%
1,396
-6
-0.4% -$3.13K
EME icon
53
Emcor
EME
$33.1B
$718K 0.22%
1,582
ETN icon
54
Eaton
ETN
$157B
$715K 0.22%
2,154
TRGP icon
55
Targa Resources
TRGP
$60.4B
$714K 0.22%
4,000
+2,000
+100% +$359K
PGR icon
56
Progressive
PGR
$124B
$710K 0.22%
2,963
-202
-6% -$50.9K
CRM icon
57
Salesforce
CRM
$134B
$700K 0.22%
2,093
-165
-7% -$52.7K
DECK icon
58
Deckers Outdoor
DECK
$13.3B
$696K 0.21%
3,426
TMO icon
59
Thermo Fisher Scientific
TMO
$211B
$691K 0.21%
1,329
MELI icon
60
Mercado Libre
MELI
$91.3B
$678K 0.21%
399
-44
-10% -$85.7K
AZN icon
61
AstraZeneca
AZN
$263B
$677K 0.21%
5,170
-1,793
-26% -$251K
NEE icon
62
NextEra Energy
NEE
$187B
$656K 0.2%
9,147
-239
-3% -$18.6K
SNPS icon
63
Synopsys
SNPS
$71.5B
$641K 0.2%
1,320
LIN icon
64
Linde
LIN
$237B
$628K 0.19%
1,499
-827
-36% -$377K
RMD icon
65
ResMed
RMD
$28.3B
$607K 0.19%
2,655
-25
-0.9% -$6.02K
EQIX icon
66
Equinix
EQIX
$107B
$602K 0.19%
638
-11
-2% -$10.1K
CPRT icon
67
Copart
CPRT
$25.9B
$601K 0.19%
10,466
PG icon
68
Procter & Gamble
PG
$343B
$599K 0.18%
3,571
-593
-14% -$101K
IBN icon
69
ICICI Bank
IBN
$106B
$579K 0.18%
19,407
-2
-0% -$60
ADBE icon
70
Adobe
ADBE
$89.5B
$573K 0.18%
1,288
-155
-11% -$76.7K
CSX icon
71
CSX Corp
CSX
$98.6B
$546K 0.17%
16,925
+8,039
+90% +$276K
SMFG icon
72
Sumitomo Mitsui Financial
SMFG
$166B
$540K 0.17%
37,262
RCL icon
73
Royal Caribbean
RCL
$78.7B
$526K 0.16%
2,278
-656
-22% -$145K
FLEX icon
74
Flex
FLEX
$43.4B
$524K 0.16%
13,659
IVV icon
75
iShares Core S&P 500 ETF
IVV
$876B
$515K 0.16%
875

Similar funds

Covenant Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Covenant Partners held 184 positions worth $324M, down 5.6% from $344M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Covenant Partners withdrew a net $15M in Q4 2024, closing 30 positions and reducing 72 holdings. Its most notable exit was Merck, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.6% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Covenant Partners opened a new position in Carlyle Group worth $309K.

  • Covenant Partners's largest Q4 2024 buy was Carlyle Group: 6,129 shares worth $309K.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q4 2024, an estimated $2.11M increase.
  • Covenant Partners's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $4.04M.
  • Covenant Partners fully exited Merck in Q4 2024, selling an estimated $1.34M.
  • Covenant Partners's ten largest holdings make up 69% of its $324M portfolio in Q4 2024.
  • Covenant Partners opened 7 new positions and closed 30 in Q4 2024.
  • Covenant Partners's portfolio value fell 5.6% quarter-over-quarter to $324M.

Based on Covenant Partners's 13F filing for Q4 2024, filed 14 Feb 2025.